[The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
作者信息
Keller L, Rétsági G, Sebestyén M, Diczendy S, Erdélyi G
出版信息
Z Gesamte Inn Med. 1966 Mar 15;21(6):169-72.
PMID:5988081
Abstract
摘要
相似文献
1
[The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
Z Gesamte Inn Med. 1966 Mar 15;21(6):169-72.
2
[Action of a 2.2 percent solution of androsterone, in chlorphenisate, on the serum lipoproteins of low density (LDL) in patients resistant to diet therapy].
Arq Bras Cardiol. 1966 Apr;19(2):111-26.
3
[Action of ethyl chlorophenoxyisobutyrate (CPIB) on blood lipids].
Rev Bras Med. 1965 Nov;22(11):702-7.
4
[Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
Dtsch Med Wochenschr. 1967 Dec 15;92(50):2302-8. doi: 10.1055/s-0028-1106136.
5
[Effect of Atromid on blood lipids in patients with hyperlipemia].
Ter Arkh. 1968 Mar;40(3):15-20.
6
[Prolonged use of atromid in patients with coronary arteriosclerosis].
Kardiologiia. 1967 Oct;7(10):32-5.
7
[Clinical-experimental studies on lipid metabolism using Regelan].
Wien Klin Wochenschr. 1967 Sep 29;79(39):720-2.
8
Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
Henry Ford Hosp Med J. 1965 Dec;13(4):447-56.
9
The effect of clofibrate on raised serum lipid levels.
N Z Med J. 1968 Oct;68(437):231-4.
10
Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
Acta Ophthalmol (Copenh). 1968;46(2):162-70. doi: 10.1111/j.1755-3768.1968.tb05172.x.
Zotero 插件